ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation dated 25th April, 2024 received from our RTA.25-04-2024
25-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith a copy of newspaper advertisement related to Notice of claiming shares from Company''s Unclaimed Suspense Account published in English language newspaper - Business Standard on 23rd April, 2024.23-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company ALEMBIC PHARMACEUTICALS LTD. 2 CIN NO. L24230GJ2010PLC061123 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2023-24, 2024-25 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) Not Applicable 8Quantum of (d), which has been met from (c)(e)* Not Applicable 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Not Applicable Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2022-23, 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Manisha SarafDesignation :-Company Secretary Name of the Chief Financial Officer :- Rajkumar Baheti Designation : -Director Finance and CFO Date: 19/04/202419-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyALEMBIC PHARMACEUTICALS LTD. 2CIN NO.L24230GJ2010PLC061123 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Manisha Saraf Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Rajkumar Baheti Designation: Director Finance and CFO EmailId: [email protected] Date: 19/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.19-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the Intimation dated 19th April, 2024 received from out RTA.19-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The exchange is hereby informed that the Company will hold Post Results Conference Call on Thursday, 9th May, 2024 as per the enclosed details.18-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Intimation for To Consider The Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2024
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 ,inter alia, to consider and approve 1. Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2024. 2. Dividend on equity shares, if any, for the financial year ended 31st March, 2024. Pursuant to the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st April, 2024, will re-open 48 hours after the declaration of the financial results18-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Please find attached herewith the Certificate under Regulation 40(9) of SEBI LODR Regulations, 2015 for the Financial Year ended on 31st March, 2024 received from M/s. Samdani Shah & Kabra, Practicing Company Secretaries.15-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 15th April, 2024 received from our RTA.15-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached the newspaper advertisement of Postal Ballot and E-voting Notice11-04-2024